FdaApplication

ANDA 205807

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA
application_typeANDA
approval_date2017-03-10

Products (2)

ProductActive ingredientStrengthDosage form
GABAPENTINGABAPENTIN800MGTABLET;ORAL
GABAPENTINGABAPENTIN600MGTABLET;ORAL

2 products